Surgery Partners, Inc.
SGRY
$24.05
-$0.11-0.46%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.96% | 8.55% | 7.10% | 8.03% | 11.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.96% | 8.55% | 7.10% | 8.03% | 11.16% |
| Cost of Revenue | 9.77% | 6.67% | 4.96% | 6.69% | 9.04% |
| Gross Profit | 10.56% | 14.96% | 14.50% | 12.63% | 18.69% |
| SG&A Expenses | -3.96% | 19.49% | 16.62% | 18.30% | 27.81% |
| Depreciation & Amortization | 28.47% | 9.36% | -2.48% | 2.87% | 8.06% |
| Other Operating Expenses | -20.97% | -2.94% | 42.00% | 54.82% | 36.41% |
| Total Operating Expenses | 9.89% | 7.45% | 5.42% | 7.51% | 10.31% |
| Operating Income | 10.34% | 14.95% | 17.14% | 11.08% | 16.27% |
| Income Before Tax | 8.74% | 53.49% | 149.39% | 22.39% | -12.37% |
| Income Tax Expenses | 450.00% | 121.69% | -72.06% | -101.29% | -85.71% |
| Earnings from Continuing Operations | -5.45% | 47.04% | 248.90% | 55.52% | 4.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.82% | -14.56% | -15.10% | -3.95% | -6.02% |
| Net Income | -76.68% | 37.87% | 100.65% | 78.21% | -9.58% |
| EBIT | 10.34% | 14.95% | 17.14% | 11.08% | 16.27% |
| EBITDA | 14.39% | 13.66% | 12.34% | 9.16% | 14.33% |
| EPS Basic | -51.43% | 52.05% | 100.53% | 83.50% | 9.55% |
| Normalized Basic EPS | 103.23% | 111.58% | 106.39% | 101.49% | 85.83% |
| EPS Diluted | -49.95% | 51.86% | 100.22% | 83.22% | 9.13% |
| Normalized Diluted EPS | 103.25% | 111.61% | 106.52% | 101.60% | 85.78% |
| Average Basic Shares Outstanding | 5.33% | 14.02% | 24.28% | 36.65% | 36.60% |
| Average Diluted Shares Outstanding | 4.96% | 13.59% | 24.69% | 36.25% | 36.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
